Affiliation: GlaxoSmithKline Research and Development
- Yang B, Brown K, Chen L, Carrick K, Clifton L, McNulty J, et al. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol. 2004;4:23 pubmed..These data suggest that serum adiponectin can serve as a biomarker for both in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin resistance and dyslipidemia in rats. ..
- Yang B, Lin P, Carrick K, McNulty J, Clifton L, Winegar D, et al. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats. Biochem Biophys Res Commun. 2005;334:176-82 pubmed....